The FDA has taken several more steps toward a 21st century regulatory framework overseeing personalized medicine. In April, FDA’s Elizabeth Mansfield confirmed the imminent publication of a draft FDA guidance on the development and labeling of companion diagnostics. The guidance will … Continue reading at ComplianceZen.com →
Menu